Anew Medical Acquires License for Nanoject From Transfertech Sherbrooke; Shares Surge Pre-Bell

MT Newswires Live08-21

Anew Medical (WENA) said Wednesday it signed an exclusive worldwide license agreement with Transfertech Sherbrooke for Nanoject.

Financial terms were not disclosed.

Nanoject is a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines.

Shares of the company jumped over 48% in recent premarket activity Wednesday.

Price: 1.53, Change: +0.50, Percent Change: +48.54

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment